(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | -134.83%-3.39M | -1.44M |
Payments to suppliers for goods and services | -134.83%-3.39M | ---1.44M |
Direct interest received | --50.59K | ---- |
Operating cash flow | -131.32%-3.34M | ---1.44M |
Investing cash flow | ||
Cash flow from continuing investing activities | -757.22%-14.02M | -1.64M |
Capital expenditure reported | -937.27%-13.34M | ---1.29M |
Net PPE purchase and sale | ---684.15K | ---- |
Net intangibles purchas and sale | ---- | ---349.85K |
Cash from discontinued investing activities | ||
Investing cash flow | -757.22%-14.02M | ---1.64M |
Financing cash flow | ||
Cash flow from continuing financing activities | 11.52%12.92M | 11.58M |
Net issuance payments of debt | ---- | --328.57K |
Net common stock issuance | 14.77%12.92M | --11.25M |
Cash from discontinued financing activities | ||
Financing cash flow | 11.52%12.92M | --11.58M |
Net cash flow | ||
Beginning cash position | 64,257.97%8.46M | --13.15K |
Current changes in cash | -152.19%-4.44M | --8.51M |
Effect of exchange rate changes | 136.22%20.01K | ---55.25K |
End cash Position | -52.21%4.04M | --8.46M |
Free cash from | -463.93%-17.36M | ---3.08M |
Accounting Standards | US-GAAP | US-GAAP |
No Data
No Data